ATE247456T1 - Puderförmige zusammensetzung zur nasalen anwendung - Google Patents

Puderförmige zusammensetzung zur nasalen anwendung

Info

Publication number: ATE247456T1
Authority: AT; Austria
Prior art keywords: water; absorbing; base material; drug; gel
Prior art date: 1996-02-27

Application number

AT97905398T

Other languages

English (en)

Inventor

Masahiko Dohi

Yoshihisa Nishibe

Yuji Makino

Original Assignee

Teijin Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-27

Filing date

1997-02-26

Publication date

2003-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26378964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE247456(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-02-26 Application filed by Teijin Ltd filed Critical Teijin Ltd

2003-09-15 Application granted granted Critical

2003-09-15 Publication of ATE247456T1 publication Critical patent/ATE247456T1/de

Links

239000000203 mixture Substances 0.000 title abstract 5
239000000843 powder Substances 0.000 title 1
239000000463 material Substances 0.000 abstract 7
239000003814 drug Substances 0.000 abstract 6
229940079593 drug Drugs 0.000 abstract 6
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
238000010521 absorption reaction Methods 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
239000001913 cellulose Substances 0.000 abstract 1
229920002678 cellulose Polymers 0.000 abstract 1
239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
210000003928 nasal cavity Anatomy 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Otolaryngology (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT97905398T 1996-02-27 1997-02-26 Puderförmige zusammensetzung zur nasalen anwendung ATE247456T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP3955396		1996-02-27
JP4107996		1996-02-28
PCT/JP1997/000541 WO1997031626A1 (en)	1996-02-27	1997-02-26	Powdery composition for nasal administration

Publications (1)

Publication Number	Publication Date
ATE247456T1 true ATE247456T1 (de)	2003-09-15

Family

ID=26378964

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97905398T ATE247456T1 (de)	1996-02-27	1997-02-26	Puderförmige zusammensetzung zur nasalen anwendung

Country Status (13)

Country	Link
US (3)	US6881423B2 (de)
EP (1)	EP0943326B2 (de)
JP (1)	JP3634380B2 (de)
KR (1)	KR100568436B1 (de)
CN (1)	CN1155368C (de)
AT (1)	ATE247456T1 (de)
AU (1)	AU722319B2 (de)
CA (1)	CA2247191C (de)
DE (1)	DE69724272T3 (de)
DK (1)	DK0943326T4 (de)
ES (1)	ES2205177T5 (de)
PT (1)	PT943326E (de)
WO (1)	WO1997031626A1 (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3634380B2 (ja) *	1996-02-27	2005-03-30	帝人株式会社	粉末状経鼻投与組成物
TWI243687B (en)	1998-04-21	2005-11-21	Teijin Ltd	Pharmaceutical composition for application to mucosa
US6428805B1 (en) *	1998-08-26	2002-08-06	Teijin Limited	Powdery nasal compositions
ES2252993T3 (es) *	1998-12-09	2006-05-16	Chiron Corporation	Administracion de agentes neurotroficos al sistema nervioso central.
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
AR026073A1 (es)	1999-10-20	2002-12-26	Nycomed Gmbh	Composicion farmaceutica acuosa que contiene ciclesonida
ATE420630T1 (de) *	2000-11-29	2009-01-15	Itoham Foods Inc	Pulverzubereitungen und verfahren zu ihrer herstellung
GB2378383A (en) *	2001-06-06	2003-02-12	Gursharan Moonga	Nasal delivery of pharmaceutical compositions in powder form
KR20030027108A (ko) *	2001-07-05	2003-04-03	트렌스레셔널 리서치 가부시키가이샤	인슐린의 경비 투여용 조성물
KR20040058324A (ko) *	2001-11-26	2004-07-03	다이이찌 산토리 파마 가부시키가이샤	경비흡수용 의약 조성물
WO2003080149A2 (en)	2002-03-20	2003-10-02	Mannkind Corporation	Inhalation apparatus
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
US20080260838A1 (en) *	2003-08-01	2008-10-23	Mannkind Corporation	Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
US7714011B2 (en) *	2002-09-13	2010-05-11	Zicam, Llc	Compositions to reduce congestion and methods for application thereof to the nasal membrane
US7638138B2 (en)	2003-02-21	2009-12-29	Translational Research, Ltd.	Compositions for nasal administration of pharmaceuticals
WO2004084859A2 (en)	2003-03-21	2004-10-07	Nastech Pharmaceutical Company Inc.	Nasal calcitonin formulations containing chlorobutanol
AU2003220808B2 (en)	2003-03-27	2008-08-21	Bioactis Limited	Powder medicine applicator for nasal cavity
GB0315632D0 (en)	2003-07-04	2003-08-13	West Pharm Serv Drug Res Ltd	Pharmaceutical formulations
WO2006016530A1 (ja) *	2004-08-10	2006-02-16	Translational Research, Ltd.	速効性でかつ高い吸収性を可能とする経鼻投与用組成物
PL1786784T3 (pl)	2004-08-20	2011-04-29	Mannkind Corp	Kataliza syntezy diketopiperazyn
KR101644250B1 (ko)	2004-08-23	2016-07-29	맨카인드 코포레이션	약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
US7115561B2 (en) *	2004-09-22	2006-10-03	Patterson James A	Medicament composition and method of administration
PL1824450T3 (pl) *	2004-10-11	2013-04-30	Nasaleze Patents Ltd	Kompozycje do podawania donosowego
GB2420707A (en) *	2004-10-11	2006-06-07	Nasaleze Patents Ltd	Compositions for intranasal administration
US8202550B2 (en)	2004-10-11	2012-06-19	Nasaleze Ppm Limited	Compositions for intranasal administration
WO2007022345A2 (en) *	2005-08-17	2007-02-22	Fleming And Company, Pharmaceuticals	Vitamin b12 nasal spray and method of use
JP5276982B2 (ja)	2005-08-26	2013-08-28	ボードオブトラスティーズオブザレランドスタンフォードジュニアユニバーシティ	オキシトシンの投与による頭痛の処置のための方法
CN104324362B (zh)	2005-09-14	2018-04-24	曼金德公司	以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
IN2015DN00888A (de)	2006-02-22	2015-07-10	Mannkind Corp
US8337817B2 (en)	2006-12-26	2012-12-25	Shin Nippon Biomedical Laboratories, Ltd.	Preparation for transnasal application
JP2011500850A (ja) *	2007-10-24	2011-01-06	マンカインドコーポレイション	Ｇｌｐ−１による副作用を防止する方法
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
ES2929343T3 (es)	2008-06-13	2022-11-28	Mannkind Corp	Inhalador de polvo seco accionado por aspiración para la administración de fármacos
KR101628410B1 (ko)	2008-06-20	2016-06-08	맨카인드 코포레이션	흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI614024B (zh)	2008-08-11	2018-02-11	曼凱公司	超快起作用胰島素之用途
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da)	2009-03-11	2013-12-16	Mannkind Corp	Apparat, system og fremgangsmåde til at måle modstand i en inhalator
WO2010131486A1 (en)	2009-05-15	2010-11-18	Shin Nippon Biomedical Laboratories, Ltd.	Intranasal pharmaceutical compositions with improved pharmacokinetics
CN104721825B (zh)	2009-06-12	2019-04-12	曼金德公司	具有确定比表面积的二酮哌嗪颗粒
WO2011013003A2 (en) *	2009-07-31	2011-02-03	Shin Nippon Biomedical Laboratories, Ltd.	Intranasal granisetron and nasal applicator
PT2474559E (pt) *	2009-09-02	2015-04-13	Nippon Soda Co	Partículas de hidroxipropilcelulose
ES2623328T3 (es) *	2009-09-18	2017-07-11	Sitec Pharmabio Sl	Procedimiento para la deshidratación de productos en polvo
WO2011056889A1 (en)	2009-11-03	2011-05-12	Mannkind Corporation	An apparatus and method for simulating inhalation efforts
ES2663335T3 (es)	2010-03-19	2018-04-12	Daiichi Sankyo Company, Limited	Composición para administración transnasal y método para prepararla
IL223742A (en)	2010-06-21	2016-06-30	Mannkind Corp	A dry powder inhaler and preparation for it
AU2012236150B2 (en)	2011-04-01	2016-03-31	Mannkind Corporation	Blister package for pharmaceutical cartridges
SE536091C2 (sv)	2011-04-14	2013-04-30	Pep Tonic Medical Ab	Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
US20130045958A1 (en)	2011-05-13	2013-02-21	Trimel Pharmaceuticals Corporation	Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
AR086400A1 (es)	2011-05-13	2013-12-11	Trimel Pharmaceuticals Corp	Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US9757388B2 (en)	2011-05-13	2017-09-12	Acerus Pharmaceuticals Srl	Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
BR112014009686A2 (pt)	2011-10-24	2018-08-07	Mannkind Corp	composição analgésica inalável, pó seco e método para tratar dor
JP5717658B2 (ja) *	2012-01-13	2015-05-13	シスメックス株式会社	副腎皮質刺激ホルモンの検出方法および吸着剤
US9789071B2 (en)	2012-06-27	2017-10-17	G2B Pharma, Inc.	Intranasal formulation of epinephrine for the treatment of anaphylaxis
CN104619369B (zh)	2012-07-12	2018-01-30	曼金德公司	干粉药物输送系统和方法
US10159644B2 (en)	2012-10-26	2018-12-25	Mannkind Corporation	Inhalable vaccine compositions and methods
HUE050050T2 (hu)	2013-03-04	2020-11-30	Besins Healthcare Lu Sarl	Hordozórészecskékhez kötõdõ hatóanyag nanorészecskéket tartalmazó száraz gyógyászati kompozíciók
US11744838B2 (en)	2013-03-15	2023-09-05	Acerus Biopharma Inc.	Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
AU2014228415B2 (en)	2013-03-15	2018-08-09	Mannkind Corporation	Microcrystalline diketopiperazine compositions and methods
MX375448B (es)	2013-07-18	2025-03-06	Mannkind Corp	Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US11446127B2 (en)	2013-08-05	2022-09-20	Mannkind Corporation	Insufflation apparatus and methods
MX2016002705A (es) *	2013-09-03	2016-09-06	G2B Pharma Inc	Formulacion intranasal para el tratamiento por reanimacion cardiopulmonar (rcp), mantenimiento cardiaco vital (cls), de anafilaxia y/o reacciones anafilactoides.
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
SG11201705591PA (en)	2015-01-07	2017-08-30	Trigemina Inc	Magnesium-containing oxytocin formulations and methods of use
JP7093559B2 (ja)	2016-04-12	2022-06-30	トライジェミナ，インコーポレイテッド	マグネシウム含有オキシトシン製剤および使用の方法
US11744967B2 (en)	2017-09-26	2023-09-05	Shin Nippon Biomedical Laboratories, Ltd.	Intranasal delivery devices
CA3083757A1 (en) *	2017-11-27	2019-05-31	Aska Pharmaceutical Co., Ltd.	Powder preparation for nasal administration
CN108158978A (zh) *	2018-03-26	2018-06-15	厦门传福堂药业有限公司	一种高分子水性凝胶及其制备方法和用途
CN113784703A (zh) *	2019-05-16	2021-12-10	株式会社新日本科学	经鼻施予用粉末制剂及其制造方法
WO2022132018A1 (en) *	2020-12-16	2022-06-23	Liw Innovation Ab	A new powder composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6034925B2 (ja) *	1979-07-31	1985-08-12	帝人株式会社	持続性鼻腔用製剤およびその製造法
JPS607965B2 (ja)	1980-08-07	1985-02-28	帝人株式会社	鼻腔粘膜投与用粉剤の製造法
JPS59163313A (ja) *	1983-03-09	1984-09-14	Teijin Ltd	経鼻投与用ペプチドホルモン類組成物
JPS6032714A (ja)	1983-08-01	1985-02-19	Teijin Ltd	鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
EP0187433B1 (de)	1983-08-01	1990-12-27	Teijin Limited	Pulverige pharmazeutische Zusammensetzung zur Anwendung auf die Schleimhaut der Mund- oder Nasenhöhle
JPS6034925A (ja)	1983-08-04	1985-02-22	Mitsubishi Chem Ind Ltd	２−ヒドロキシイソフタルアルデヒド類の製造法
JPS60224616A (ja) *	1984-04-24	1985-11-09	Teijin Ltd	経鼻投与用組成物
JPS6242888A (ja)	1985-08-21	1987-02-24	カシオ計算機株式会社	太陽電池を備えたｉｃカ−ド
GB2193891B (en)	1986-08-18	1990-07-25	Sandoz Ltd	Nasal pharmaceutical composition containing a somatostatin anologue.
JP3068924B2 (ja)	1990-11-29	2000-07-24	旭硝子株式会社	熱線遮断膜
EP0571671B1 (de)	1992-05-26	1997-09-17	The Procter & Gamble Company	Pulverförmige pharmazeutische Zusammensetzung
KR100208979B1 (ko) *	1992-06-12	1999-07-15	야스이 쇼사꾸	기도내 투여용 제제
US5578324A (en) *	1993-07-30	1996-11-26	Teijin Limited	Peptide proteinaceous drug nasal powder composition
JPH07242550A (ja)	1994-03-02	1995-09-19	Teijin Ltd	二次性副甲状腺機能亢進症治療剤
JP3634380B2 (ja) *	1996-02-27	2005-03-30	帝人株式会社	粉末状経鼻投与組成物

1997
- 1997-02-26 JP JP53078797A patent/JP3634380B2/ja not_active Expired - Fee Related
- 1997-02-26 AT AT97905398T patent/ATE247456T1/de active
- 1997-02-26 DK DK97905398T patent/DK0943326T4/da active
- 1997-02-26 CN CNB97193861XA patent/CN1155368C/zh not_active Expired - Fee Related
- 1997-02-26 WO PCT/JP1997/000541 patent/WO1997031626A1/ja not_active Ceased
- 1997-02-26 ES ES97905398T patent/ES2205177T5/es not_active Expired - Lifetime
- 1997-02-26 EP EP97905398A patent/EP0943326B2/de not_active Expired - Lifetime
- 1997-02-26 US US09/125,814 patent/US6881423B2/en not_active Expired - Fee Related
- 1997-02-26 PT PT97905398T patent/PT943326E/pt unknown
- 1997-02-26 KR KR1019980706662A patent/KR100568436B1/ko not_active Expired - Fee Related
- 1997-02-26 CA CA002247191A patent/CA2247191C/en not_active Expired - Fee Related
- 1997-02-26 AU AU22302/97A patent/AU722319B2/en not_active Ceased
- 1997-02-26 DE DE69724272T patent/DE69724272T3/de not_active Expired - Lifetime
2004
- 2004-06-04 US US10/860,058 patent/US7731990B2/en not_active Expired - Fee Related
2009
- 2009-11-02 US US12/610,901 patent/US8206748B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR100568436B1 (ko)	2007-04-25
EP0943326B1 (de)	2003-08-20
US20100047206A1 (en)	2010-02-25
EP0943326B2 (de)	2006-12-20
CA2247191A1 (en)	1997-09-04
US7731990B2 (en)	2010-06-08
DK0943326T3 (da)	2003-12-08
WO1997031626A1 (en)	1997-09-04
CN1216464A (zh)	1999-05-12
DE69724272D1 (de)	2003-09-25
EP0943326A4 (de)	2000-12-20
US20020012688A1 (en)	2002-01-31
AU2230297A (en)	1997-09-16
PT943326E (pt)	2003-12-31
ES2205177T5 (es)	2007-08-01
EP0943326A1 (de)	1999-09-22
CA2247191C (en)	2005-01-04
DE69724272T3 (de)	2007-05-10
US8206748B2 (en)	2012-06-26
AU722319B2 (en)	2000-07-27
DE69724272T2 (de)	2004-06-09
ES2205177T3 (es)	2004-05-01
US6881423B2 (en)	2005-04-19
KR19990087261A (ko)	1999-12-15
JP3634380B2 (ja)	2005-03-30
CN1155368C (zh)	2004-06-30
DK0943326T4 (da)	2007-01-22
US20040219108A1 (en)	2004-11-04

Legal Events

Date

Code

Title

Description

2004-05-15

UEP

Publication of translation of european patent specification

Ref document number: 0943326

Country of ref document: EP

2007-03-15

UEP